Reduction of carcinogen-induced mammary cancer incidence in rats by early treatment with hormones or drugs.
D000818:Animals; D001551:Benz(a)Anthracenes; D002273:Carcinogens; D004048:Diethylamines / Q000627:therapeutic use; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004958:Estradiol / Q000627:therapeutic use*; D004965:Estrogen Antagonists; D004967:Estrogens / Q000627:therapeutic use; D000431:Ethanol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control*; D010647:Phenyl Ethers / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use*; D051381:Rats; D013997:Time Factors
D001551:Benz(a)Anthracenes; D002273:Carcinogens; D004048:Diethylamines; D004965:Estrogen Antagonists; D004967:Estrogens; D010647:Phenyl Ethers; D000431:Ethanol; D011374:Progesterone; D004958:Estradiol; D004295:Dihydroxyphenylalanine; D006220:Haloperidol